cysteine has been researched along with Disbacteriosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, K; Hou, L; Huang, N; Jiang, H; Lin, M; Shang, R; Shi, Z; Wang, J; Wei, Y; Xiao, L; Yang, J; Yao, S; Yin, N; You, Y; Zhang, J; Zhang, W; Zhao, F; Zhao, Y | 1 |
| Bar-Yoseph, R; Bentur, L; Gur, M; Hakim, F; Hanna, M; Laghi, L; Levanon, S; Marazzato, M; Masarweh, K; Wilschanski, M; Zuckerman-Levin, N | 1 |
| Aldrovandi, GM; Clark, JL; D'Aquila, R; Elliott, J; Fulcher, JA; Gorbach, PM; Kipke, MD; Li, F; Mustanski, B; Shoptaw, S; Tobin, NH; Zabih, S | 1 |
| Agüera, E; Aguilar-Luque, M; Caballero-Villarraso, J; Escribano, BM; Feijóo, M; García-Maceira, FI; Luque, E; Ramirez, V; Santamaria, A; Torres, LA; Túnez, I | 1 |
4 other study(ies) available for cysteine and Disbacteriosis
| Article | Year |
|---|---|
Unfavourable intrauterine environment contributes to abnormal gut microbiome and metabolome in twins.
Topics: Cysteine; Dysbiosis; Feces; Female; Gastrointestinal Microbiome; Humans; Infant; Infant, Newborn; Metabolome; Pregnancy; RNA, Ribosomal, 16S | 2022 |
The effect of probiotic administration on metabolomics and glucose metabolism in CF patients.
Topics: Adolescent; Adult; Arabinose; Blood Glucose; Blood Glucose Self-Monitoring; Child; Cysteine; Cystic Fibrosis; Cytokines; Diabetes Mellitus; Dysbiosis; Glucose Intolerance; Glutamine; Humans; Indoles; Insulin Resistance; Lactates; Lactulose; Mannitol; Pilot Projects; Probiotics; Prospective Studies; Quality of Life; Young Adult | 2022 |
Gut dysbiosis and inflammatory blood markers precede HIV with limited changes after early seroconversion.
Topics: B-Cell Activating Factor; Bile Acids and Salts; Biomarkers; Cross-Sectional Studies; Cysteine; Dysbiosis; HIV Infections; Humans; Interleukin-8; Lipids; Lithocholic Acid; Serine; Seroconversion; Sphingosine; Sulfates; Tumor Necrosis Factor-alpha | 2022 |
Dose-dependent S-allyl cysteine ameliorates multiple sclerosis disease-related pathology by reducing oxidative stress and biomarkers of dysbiosis in experimental autoimmune encephalomyelitis.
Topics: Acute-Phase Proteins; Animals; Biomarkers; Carrier Proteins; Cysteine; Dose-Response Relationship, Drug; Dysbiosis; Encephalomyelitis, Autoimmune, Experimental; Intestinal Mucosa; Intestines; Lipopolysaccharides; Male; Membrane Glycoproteins; Multiple Sclerosis; Oxidative Stress; Rats; Tumor Necrosis Factor-alpha | 2017 |